关注
Roy Chemaly
Roy Chemaly
Professor of Medicine
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ...
Science 359 (6371), 97-103, 2018
40142018
Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation
FM Marty, P Ljungman, RF Chemaly, J Maertens, SS Dadwal, RF Duarte, ...
New England Journal of Medicine 377 (25), 2433-2444, 2017
10322017
A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID‐19) pandemic: an international collaborative group
HO Al‐Shamsi, W Alhazzani, A Alhuraiji, EA Coomes, RF Chemaly, ...
The oncologist 25 (6), e936-e945, 2020
7922020
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)
G Chamilos, M Luna, RE Lewis, GP Bodey, R Chemaly, JJ Tarrand, ...
haematologica 91 (7), 986-989, 2006
6602006
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
FM Marty, P Ljungman, GA Papanicolaou, DJ Winston, RF Chemaly, ...
The Lancet infectious diseases 11 (4), 284-292, 2011
4052011
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation
RF Chemaly, AJ Ullmann, S Stoelben, MP Richard, M Bornhäuser, ...
New England Journal of Medicine 370 (19), 1781-1789, 2014
3972014
Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center
RF Chemaly, S Ghosh, GP Bodey, N Rohatgi, A Safdar, MJ Keating, ...
Medicine 85 (5), 278-287, 2006
3672006
Posaconazole: a broad-spectrum triazole antifungal
HA Torres, RY Hachem, RF Chemaly, DP Kontoyiannis, II Raad
The Lancet infectious diseases 5 (12), 775-785, 2005
3602005
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
A Sharma, NS Bhatt, A St Martin, MB Abid, J Bloomquist, RF Chemaly, ...
The Lancet Haematology 8 (3), e185-e193, 2021
3542021
Management of RSV infections in adult recipients of hematopoietic stem cell transplantation
JN Shah, RF Chemaly
Blood, The Journal of the American Society of Hematology 117 (10), 2755-2763, 2011
2752011
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled …
DJ Winston, JAH Young, V Pullarkat, GA Papanicolaou, R Vij, E Vance, ...
Blood, The Journal of the American Society of Hematology 111 (11), 5403-5410, 2008
2722008
Utility of Galactomannan Enzyme Immunoassay and (1,3) β-d-Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection …
RY Hachem, DP Kontoyiannis, RF Chemaly, Y Jiang, R Reitzel, I Raad
Journal of Clinical Microbiology 47 (1), 129-133, 2009
2562009
Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review
EJ Ariza-Heredia, L Nesher, RF Chemaly
Cancer letters 342 (1), 1-8, 2014
2122014
Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies
RF Chemaly, DP Shah, MJ Boeckh
Clinical infectious diseases 59 (suppl_5), S344-S351, 2014
2112014
The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment
RF Chemaly, S Simmons, C Dale Jr, SS Ghantoji, M Rodriguez, J Gubb, ...
Therapeutic advances in infectious disease 2 (3-4), 79-90, 2014
2072014
Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience
RF Chemaly, J Barbara de Parres, SJ Rehm, KA Adal, MV Lisgaris, ...
Clinical infectious diseases 34 (9), 1179-1183, 2002
2072002
A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation
FM Marty, DJ Winston, RF Chemaly, KM Mullane, TB Shore, ...
Biology of Blood and Marrow Transplantation 25 (2), 369-381, 2019
1932019
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
F El Chaer, DP Shah, RF Chemaly
Blood, The Journal of the American Society of Hematology 128 (23), 2624-2636, 2016
1862016
Colistin Is Effective in Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa in Cancer Patients
RY Hachem, RF Chemaly, CA Ahmar, Y Jiang, MR Boktour, GA Rjaili, ...
Antimicrobial agents and chemotherapy 51 (6), 1905-1911, 2007
1842007
Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials
RF Chemaly, S Chou, H Einsele, P Griffiths, R Avery, RR Razonable, ...
Clinical Infectious Diseases 68 (8), 1420-1426, 2019
1792019
系统目前无法执行此操作,请稍后再试。
文章 1–20